OBJECTIVE: Resting energy expenditure (EE) is a major contributor to the total EE and thus plays an important role in body weight regulation. Adaptive thermogenesis is a major component of EE in rodents, but little is known on the effects of exposure of humans to mild and sustainable reduction in environmental temperature. DESIGN: To characterize the dynamic changes in continuously measured resting EE, substrate utilization, and hormonal axes simultaneously in response to mild reduction in environmental temperature, we performed a cross-over intervention. METHODS:Twenty-five volunteers underwent two 12-h recordings of EE in whole room indirect calorimeters at 24 and 19 °C with simultaneous measurement of spontaneous movements and hormonal axes. RESULTS: Exposure to 19 °C resulted in an increase in plasma and urine norepinephrine levels (P<0.0001), and a 5.96% (P<0.001) increase in EE without significant changes in spontaneous physical activity. Exposure to the lower temperature resulted in a significant increase in free fatty acid levels (P<0.01), fasting insulin levels (P<0.05), and a marginal decrease in postprandial glucose levels. A small but significant (P<0.002) increase in serum free thyroxine and urinary free cortisol (P<0.05) was observed at 19 °C. CONCLUSIONS: Our observations indicate that exposure to 19 °C, a mild and tolerable cold temperature, results in a predictable increase in EE driven by a sustained rise in catecholamine and the activation of counter-regulatory mechanisms.
RCT Entities:
OBJECTIVE: Resting energy expenditure (EE) is a major contributor to the total EE and thus plays an important role in body weight regulation. Adaptive thermogenesis is a major component of EE in rodents, but little is known on the effects of exposure of humans to mild and sustainable reduction in environmental temperature. DESIGN: To characterize the dynamic changes in continuously measured resting EE, substrate utilization, and hormonal axes simultaneously in response to mild reduction in environmental temperature, we performed a cross-over intervention. METHODS: Twenty-five volunteers underwent two 12-h recordings of EE in whole room indirect calorimeters at 24 and 19 °C with simultaneous measurement of spontaneous movements and hormonal axes. RESULTS: Exposure to 19 °C resulted in an increase in plasma and urine norepinephrine levels (P<0.0001), and a 5.96% (P<0.001) increase in EE without significant changes in spontaneous physical activity. Exposure to the lower temperature resulted in a significant increase in free fatty acid levels (P<0.01), fasting insulin levels (P<0.05), and a marginal decrease in postprandial glucose levels. A small but significant (P<0.002) increase in serum free thyroxine and urinary free cortisol (P<0.05) was observed at 19 °C. CONCLUSIONS: Our observations indicate that exposure to 19 °C, a mild and tolerable cold temperature, results in a predictable increase in EE driven by a sustained rise in catecholamine and the activation of counter-regulatory mechanisms.
Authors: Wouter D van Marken Lichtenbelt; Joost W Vanhommerig; Nanda M Smulders; Jamie M A F L Drossaerts; Gerrit J Kemerink; Nicole D Bouvy; Patrick Schrauwen; G J Jaap Teule Journal: N Engl J Med Date: 2009-04-09 Impact factor: 91.245
Authors: Aaron M Cypess; Sanaz Lehman; Gethin Williams; Ilan Tal; Dean Rodman; Allison B Goldfine; Frank C Kuo; Edwin L Palmer; Yu-Hua Tseng; Alessandro Doria; Gerald M Kolodny; C Ronald Kahn Journal: N Engl J Med Date: 2009-04-09 Impact factor: 91.245
Authors: Kirsi A Virtanen; Martin E Lidell; Janne Orava; Mikael Heglind; Rickard Westergren; Tarja Niemi; Markku Taittonen; Jukka Laine; Nina-Johanna Savisto; Sven Enerbäck; Pirjo Nuutila Journal: N Engl J Med Date: 2009-04-09 Impact factor: 91.245
Authors: Frank M Sacks; George A Bray; Vincent J Carey; Steven R Smith; Donna H Ryan; Stephen D Anton; Katherine McManus; Catherine M Champagne; Louise M Bishop; Nancy Laranjo; Meryl S Leboff; Jennifer C Rood; Lilian de Jonge; Frank L Greenway; Catherine M Loria; Eva Obarzanek; Donald A Williamson Journal: N Engl J Med Date: 2009-02-26 Impact factor: 91.245
Authors: Aaron M Cypess; Yih-Chieh Chen; Cathy Sze; Ke Wang; Jeffrey English; Onyee Chan; Ashley R Holman; Ilan Tal; Matthew R Palmer; Gerald M Kolodny; C Ronald Kahn Journal: Proc Natl Acad Sci U S A Date: 2012-06-04 Impact factor: 11.205
Authors: Marc L Reitman; Victor Dishy; Allison Moreau; William S Denney; Chengcheng Liu; Walter K Kraft; Alex V Mejia; Mark A Matson; S Aubrey Stoch; John A Wagner; Eseng Lai Journal: J Clin Pharmacol Date: 2011-12-12 Impact factor: 3.126
Authors: Robert J Brychta; Shan Huang; Juan Wang; Brooks P Leitner; Jacob D Hattenbach; Sarah L Bell; Laura A Fletcher; Rachel Perron Wood; Christopher R Idelson; Courtney J Duckworth; Suzanne McGehee; Amber B Courville; Shanna B Bernstein; Marc L Reitman; Aaron M Cypess; Kong Y Chen Journal: J Clin Endocrinol Metab Date: 2019-10-01 Impact factor: 5.958
Authors: Paul Lee; Joyce D Linderman; Sheila Smith; Robert J Brychta; Juan Wang; Christopher Idelson; Rachel M Perron; Charlotte D Werner; Giao Q Phan; Udai S Kammula; Electron Kebebew; Karel Pacak; Kong Y Chen; Francesco S Celi Journal: Cell Metab Date: 2014-02-04 Impact factor: 27.287
Authors: Paul Lee; Robert J Brychta; Joyce Linderman; Sheila Smith; Kong Y Chen; Francesco S Celi Journal: J Clin Endocrinol Metab Date: 2012-11-12 Impact factor: 5.958
Authors: P Lee; J Linderman; S Smith; R J Brychta; R Perron; C Idelson; C D Werner; K Y Chen; F S Celi Journal: Osteoporos Int Date: 2013-08-03 Impact factor: 4.507